Thank you to our speakers, sponsors, and delegates who joined us in Singapore! If you are interested in the 2026 event, please get in touch at info@hansonwade.com
Empowering Timely & Affordable Drug-Diagnostic Access Across APAC Through Harmonized Trial Management, Policy Shaping, & Testing Adoption
With rising demand for targeted therapies and testing access, the Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies. In under a year, Singapore has accelerated public-private partnerships to scale genomic testing, China has expanded national reimbursement for liquid biopsies, and Japan has refined its regulatory framework for companion diagnostic approvals.
In its second year, the World Liquid Biopsy & Companion Diagnostics Summit APAC united 100+ leaders across biopharma, diagnostics, regulation, and healthcare to drive the co-development and commercialization of affordable, scalable, and timely testing solutions.
Spanning oncology to neurology, chronic and rare diseases, this APAC-dedicated forum addressed the full drug-diagnostic co-development journey, where precision partnerships are formed, regional strategies aligned, and precision medicine innovation accelerated for improved patient access across the region.
2025 Speakers
演讲者 | 講演者 | penceramah
Attending Companies Included:
与会公司 | 参加企業 | Syarikat yang Hadir